REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 120 filers reported holding REVOLUTION MEDICINES INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,733,986 | -34.3% | 62,644 | -36.5% | 0.00% | 0.0% |
| Q2 2023 | $2,639,290 | +70.6% | 98,665 | +38.2% | 0.00% | – |
| Q1 2023 | $1,546,871 | +3495.8% | 71,416 | +3854.4% | 0.00% | – |
| Q4 2022 | $43,019 | -39.4% | 1,806 | -50.1% | 0.00% | – |
| Q3 2022 | $71,000 | +12.7% | 3,622 | +11.8% | 0.00% | – |
| Q2 2022 | $63,000 | -90.2% | 3,239 | -87.2% | 0.00% | – |
| Q1 2022 | $646,000 | -44.5% | 25,269 | -45.3% | 0.00% | – |
| Q4 2021 | $1,164,000 | -28.1% | 46,220 | -21.4% | 0.00% | – |
| Q3 2021 | $1,619,000 | +202.1% | 58,834 | +247.7% | 0.00% | – |
| Q2 2021 | $536,000 | -4.5% | 16,919 | +38.2% | 0.00% | – |
| Q1 2021 | $561,000 | -82.8% | 12,240 | -85.1% | 0.00% | -100.0% |
| Q4 2020 | $3,259,000 | +100.7% | 82,294 | +76.3% | 0.00% | – |
| Q3 2020 | $1,624,000 | +29.1% | 46,677 | +17.1% | 0.00% | – |
| Q2 2020 | $1,258,000 | +580.0% | 39,876 | +372.9% | 0.00% | – |
| Q1 2020 | $185,000 | – | 8,433 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |